Log in

Systematic review to evaluate the safety, efficacy and economical outcomes of the Vibrant Soundbridge for the treatment of sensorineural hearing loss

  • Review Article
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Introduced in the late 90s, the active middle ear implant Vibrant Soundbridge (VSB) is nowadays used for hearing rehabilitation in patients with mild to severe sensorineural hearing loss (SNHL) unable to tolerate conventional hearing aids. In experienced hands, the surgical implantation is fast done, safe and highly standardized. Here, we present a systematic review, after more than 15 years of application, to determine the efficacy/effectiveness and cost-effectiveness, as well as patient satisfaction with the VSB active middle ear implant in the treatment of mild to severe SNHL. A systematic search of electronic databases, investigating the safety and effectiveness of the VSB in SNHL plus medical condition resulted in a total of 1640 papers. After removing duplicates, unrelated articles, screening against inclusion criteria and after in-depth screening, the number decreased to 37 articles. 13 articles were further excluded due to insufficient outcome data. 24 studies remained to be systematically reviewed. Data was searched on safety, efficacy and economical outcomes with the VSB. Safety-oriented outcomes included complication/adverse event rates, damage to the middle/inner ear, revision surgery/explant rate/device failure and mortality. Efficacy outcomes were divided into audiological outcomes, including hearing thresholds, functional gain, speech perception in quiet and noise, speech recognition thresholds, real ear insertion gain and subjective outcomes determined by questionnaires and patient-oriented scales. Data related to quality of life (QALY, ICER) were considered under economical outcomes. The VSB turns out to be a highly reliable and a safe device which significantly improves perception of speech in noisy situations with a high sound quality. In addition, the subjective benefit of the VSB was found to be mostly significant in all studies. Finally, implantation with the VSB proved to be a cost-effective and justified health care intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Lin HW, Bhattacharyya N (2011) Otologic diagnoses in the elderly: current utilization and predicted workload increase. Laryngoscope 121:1504–1507

    Article  PubMed  Google Scholar 

  2. Wilson DH, Walsh PG, Sanchez L, Davis AC, Taylor AW, Tucker G, Meagher I (1999) The epidemiology of hearing impairment in an Australian adult population. Int J Epidemiol 28:247–252

    Article  CAS  PubMed  Google Scholar 

  3. Kochin S (1992) MarkeTrak III identifies key factors in determining consumer satisfaction. Hear J 458:39–44

    Google Scholar 

  4. Kochin S (1992) MarkeTrak III identifies key factors in determining consumer satisfaction. Hear J 458:47–54

    Google Scholar 

  5. Moher D, Liberati A, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. PLoS Med 6(7):e1000100. doi:10.1371/journal.pmed.1000100

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cohen JA (1960) A coefficient of agreement for nominal scales. Educ Psychol Measur 20:37–46. doi:10.1177/001316446002000104

    Article  Google Scholar 

  7. Cochrane Consumers and Communication Review Group (2015) http://www.latrobe.edu.au/chcp/cochrane/resources.html. Accessed Aug 2015

  8. Evidence Analysis Library, Academy of Nutrition and Diabetics (2015) http://andevidencelibrary.com/topic.cfm?cat=1317&auth=1. Accessed Aug 2015

  9. Labassi S, Beliaeff M (2005) Retrospective of 1000 patients implanted with a Vibrant Soundbridge middle-ear implant. Cochlear Implants Int 6(Suppl 1):74–77. doi:10.1002/cii.294

    Article  PubMed  Google Scholar 

  10. FDA (2010) Esteem safety and effectiveness. Multicenter study. Prospective single arm trial

  11. Luetje CM, Brackman D, Balkany TJ, Maw J, Baker RS, Kelsall D, Backous D, Miyamoto R, Parisier S, Arts A (2002) Phase III clinical trial results with the Vibrant Soundbridge implantable middle ear hearing device: a prospective controlled multicenter study. Otolaryngol Head Neck Surg 126(2):97–107

    Article  PubMed  Google Scholar 

  12. Todt I, Seidl RO, Ernst A (2005) Hearing benefit of patients after Vibrant Soundbridge implantation. ORL J Otorhinolaryngol Relat Spec 67(4):203–206

    Article  PubMed  Google Scholar 

  13. Fisch U, Cremers CW, Lenarz T, Weber B, Babighian G, Uziel AS, Proops DW, O’Connor AF, Charachon R, Helms J, Fraysse B (2001) Clinical experience with the Vibrant Soundbridge implant device. Otol Neurotol 22(6):962–972

    Article  CAS  PubMed  Google Scholar 

  14. Fraysse B, Lavieille JP, Schmerber S, Enée V, Truy E, Vincent C, Vaneecloo FM, Sterkers O (2001) A multicenter study of the Vibrant Soundbridge middle ear implant: early clinical results and experience. Otol Neurotol 22(6):952–961

    Article  CAS  PubMed  Google Scholar 

  15. Mosnier I, Sterkers O, Bouccara D, Labassi S, Bebear JP, Bordure P, Dubreuil C, Dumon T, Frachet B, Fraysse B, Lavieille JP, Magnan J, Martin C, Meyer B, Mondain M, Portmann D, Robier A, Schmerber S, Thomassin JM, Truy E, Uziel A, Vanecloo FM, Vincent C, Ferrary E (2008) Benefit of the Vibrant Soundbridge device in patients implanted for 5 to 8 years. Ear Hear 29(2):281–284

    Article  PubMed  Google Scholar 

  16. Vincent C, Fraysse B, Lavieille JP, Truy E, Sterkers O, Vaneecloo FM (2004) A longitudinal study on postoperative hearing thresholds with the Vibrant Soundbridge device. Eur Arch Otorhinolaryngol 261(9):493–496

    Article  CAS  PubMed  Google Scholar 

  17. Schmuziger N, Schimmann F, àWengen D, Patscheke J, Probst R (2006) Long-term assessment after implantation of the Vibrant Soundbridge device. Otol Neurotol 27(2):183–188

    Article  PubMed  Google Scholar 

  18. Saliba I, Calmels MN, Wanna G, Iversenc G, James C, Deguine O, Fraysse B (2005) Binaurality in middle ear implant recipients using contralateral digital hearing AIDS. Otol Neurotol 26(4):680–685

    Article  PubMed  Google Scholar 

  19. Todt I, Seidl RO, Gross M, Ernst A (2002) Comparison of different Vibrant Soundbridge audioprocessors with conventional hearing AIDS. Otol Neurotol 23(5):669–673

    Article  PubMed  Google Scholar 

  20. Luetje CM, Brown SA, Cullen RD (2010) Vibrant Soundbridge implantable hearing device: critical review and single-surgeon short- and long-term results. Ear Nose Throat J 89(9):E9–E14

    PubMed  Google Scholar 

  21. Sziklai I, Szilvássy J (2011) Functional gain and speech understanding obtained by Vibrant Soundbridge or by open-fit hearing aid. Acta Otolaryngol 131(4):428–433. doi:10.3109/00016489.2011.557394

    Article  PubMed  Google Scholar 

  22. Sterkers O, Boucarra D, Labassi S, Bebear JP, Dubreuil C, Frachet B, Fraysse B, Lavieille JP, Magnan J, Martin C, Truy E, Uziel A, Vaneecloo FM (2003) A middle ear implant, the Symphonix Vibrant Soundbridge: retrospective study of the first 125 patients implanted in France. Otol Neurotol 24(3):427–436

    Article  PubMed  Google Scholar 

  23. Pok SM, Schlögel M, Böheim K (2010) Clinical experience with the active middle ear implant Vibrant Soundbridge in sensorineural hearing loss. Adv Otorhinolaryngol 69:51–58. doi:10.1159/000318522

    CAS  PubMed  Google Scholar 

  24. Snik AF, Cremers CW (2001) Vibrant semi-implantable hearing device with digital sound processing: effective gain and speech perception. Arch Otolaryngol Head Neck Surg 127(12):1433–1437

    Article  CAS  PubMed  Google Scholar 

  25. Böheim K, Nahler A, Schlögel M (2007) Rehabilitation of high frequency hearing loss: use of an active middle ear implant. HNO 55(9):690–695

    Article  PubMed  Google Scholar 

  26. Boeheim K, Pok SM, Schloegel M, Filzmoser P (2010) Active middle ear implant compared with open-fit hearing aid in slo** high-frequency sensorineural hearing loss. Otol Neurotol 31(3):424–429. doi:10.1097/MAO.0b013e3181cabd42

    Article  PubMed  Google Scholar 

  27. Lenarz T, Weber BP, Issing PR, Gnadeberg D, Ambjørnsen K, Mack KF, Winter M (2001) Vibrant Sound Bridge System. A new kind hearing prosthesis for patients with sensorineural hearing loss. 2. Audiological results. Laryngorhinootologie 80(7):370–380

    Article  CAS  PubMed  Google Scholar 

  28. Wiedmann J (2010) Die Rehabilitation der Schallempfindungsschwerhörigkeit mittels teilimplantierbarem Vibrant Soundbridge System. Dissertation, University of Ulm

  29. Garin P, Thill MP, Gerard JM (2002) Speech discrimination in background noise with the Vibrant® Soundbridge™ middle ear implant. Otorhinolaryngol Nova 12:119–123

    Article  Google Scholar 

  30. Garin P, Debaty M, Galle C (2005) Hearing in noise with the vibrant Soundbridge middle-ear implant. Cochlear Implants Int 6(Suppl 1):72–74. doi:10.1002/cii.293

    Article  PubMed  Google Scholar 

  31. Uziel A, Mondain M, Hagen P, Dejean F, Doucet G (2003) Rehabilitation for high-frequency sensorineural hearing impairment in adults with the Symphonix Vibrant Soundbridge: a comparative study. Otol Neurotol 24(5):775–783

    Article  PubMed  Google Scholar 

  32. Snik AF, van Duijnhoven NT, Mylanus EA, Cremers CW (2006) Estimated cost-effectiveness of active middle-ear implantation in hearing-impaired patients with severe external otitis. Arch Otolaryngol Head Neck Surg 132(11):1210–1215

    Article  PubMed  Google Scholar 

  33. Snik A, Verhaegen V, Mulder J, Cremers CW (2010) Cost-effectiveness of implantable middle ear hearing devices. Adv Otorhinolaryngol 69:14–19. doi:10.1159/000318517

    PubMed  Google Scholar 

  34. Edfeldt L, Strömbäck K, Grendin J, Bunne M, Harder H, Peebo M, Eeg-Olofsson M, Petersson CM, Konradsson K (2014) Evaluation of cost-utility in middle ear implantation in the ‘Nordic School’: a multicenter study in Sweden and Norway. Acta Otolaryngol 134(1):19–25. doi:10.3109/00016489.2013.834459

    Article  PubMed  Google Scholar 

  35. Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K (2010) International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 19(4):422–437. doi:10.1002/hec.1481

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karl-Ludwig Bruchhage.

Ethics declarations

Conflict of interest

All authors have read and approved the manuscript and have no conflict of interest related to this paper.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bruchhage, KL., Leichtle, A., Schönweiler, R. et al. Systematic review to evaluate the safety, efficacy and economical outcomes of the Vibrant Soundbridge for the treatment of sensorineural hearing loss. Eur Arch Otorhinolaryngol 274, 1797–1806 (2017). https://doi.org/10.1007/s00405-016-4361-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-016-4361-2

Keywords

Navigation